WEE1 and chronic myelogenous leukemia, BCR-ABL1 positive: An inhibitor to this protein kinase could prove to be as efficacious as the tyrosine kinase inhibitor STI-571, which is used in the treatment of chronic myeloid leukaemia (Thiesing et al, 2000; Joensuu et al, 2001).